“Yeah, just looked into it a bit more and it looks to me like they’re raising enough to start launching and buy time to find a partner or a suitor.
If neither of those happen in the next qtr they’ll probably be back to the well again for a bigger chunk of shares.”
Almost four months since FDA approval. You guys are correct, given the big picture, we are looking down the barrel of another raise SOON for a significant amount of shares given the lack of a partnership. Life in the fast last for biotech!!
News 
Market Data 
Discover 
